BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension. 2004;44:595-601. [PMID: 15452024 DOI: 10.1161/01.hyp.0000145180.38707.84] [Cited by in Crossref: 218] [Cited by in F6Publishing: 100] [Article Influence: 12.8] [Reference Citation Analysis]
Number Citing Articles
1 Drummond HA, Jernigan NL, Grifoni SC. Sensing tension: epithelial sodium channel/acid-sensing ion channel proteins in cardiovascular homeostasis. Hypertension 2008;51:1265-71. [PMID: 18378856 DOI: 10.1161/HYPERTENSIONAHA.107.093401] [Cited by in Crossref: 54] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
2 Peralta CA, McClure LA, Scherzer R, Odden MC, White CL, Shlipak M, Benavente O, Pergola P. Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial. Circulation 2016;133:584-91. [PMID: 26762524 DOI: 10.1161/CIRCULATIONAHA.115.019657] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
3 Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK. Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol. 2010;298:F1078-F1094. [PMID: 20200097 DOI: 10.1152/ajprenal.00017.2010] [Cited by in Crossref: 336] [Cited by in F6Publishing: 310] [Article Influence: 30.5] [Reference Citation Analysis]
4 Polichnowski AJ, Griffin KA, Long J, Williamson GA, Bidani AK. Blood pressure-renal blood flow relationships in conscious angiotensin II- and phenylephrine-infused rats. Am J Physiol Renal Physiol 2013;305:F1074-84. [PMID: 23825067 DOI: 10.1152/ajprenal.00111.2013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
5 Shaito A, Thuan DTB, Phu HT, Nguyen THD, Hasan H, Halabi S, Abdelhady S, Nasrallah GK, Eid AH, Pintus G. Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety. Front Pharmacol 2020;11:422. [PMID: 32317975 DOI: 10.3389/fphar.2020.00422] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 32.0] [Reference Citation Analysis]
6 Masoud G, GhorbaniP , Ardestani MS. Treatment with CL316, 243 Improves Insulin Resistance by Down Regulation of Tumor Necrosis Factor-α (TNF-α) Expression. Insight Biomedical Science. 2012;2:6-9. [PMID: 22068875 DOI: 10.1161/hypertensionaha.111.173328] [Cited by in Crossref: 104] [Cited by in F6Publishing: 76] [Article Influence: 10.4] [Reference Citation Analysis]
7 Lindeman RD. Hypertension and kidney protection in the elderly: what is the evidence in 2007? Int Urol Nephrol 2007;39:669-78. [PMID: 17487566 DOI: 10.1007/s11255-007-9207-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
8 Lin JR, Zheng YJ, Zhang ZB, Shen WL, Li XD, Wei T, Ruan CC, Chen XH, Zhu DL, Gao PJ. Suppression of Endothelial-to-Mesenchymal Transition by SIRT (Sirtuin) 3 Alleviated the Development of Hypertensive Renal Injury. Hypertension 2018;72:350-60. [PMID: 29915018 DOI: 10.1161/HYPERTENSIONAHA.118.10482] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 9.3] [Reference Citation Analysis]
9 Picken M, Long J, Williamson GA, Polichnowski AJ. Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis. Hypertension 2016;68:921-8. [PMID: 27550923 DOI: 10.1161/HYPERTENSIONAHA.116.07749] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
10 Girardi A, Raschi E, Galletti S, Poluzzi E, Faldella G, Allegaert K, De Ponti F. Drug-induced renal damage in preterm neonates: state of the art and methods for early detection. Drug Saf 2015;38:535-51. [PMID: 25863473 DOI: 10.1007/s40264-015-0288-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
11 Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol 2006;290:R1153-67. [PMID: 16603656 DOI: 10.1152/ajpregu.00402.2005] [Cited by in Crossref: 184] [Cited by in F6Publishing: 146] [Article Influence: 12.3] [Reference Citation Analysis]
12 Burke M, Pabbidi MR, Farley J, Roman RJ. Molecular mechanisms of renal blood flow autoregulation. Curr Vasc Pharmacol 2014;12:845-58. [PMID: 24066938 DOI: 10.2174/15701611113116660149] [Cited by in Crossref: 77] [Cited by in F6Publishing: 48] [Article Influence: 12.8] [Reference Citation Analysis]
13 Pan X, Geng X, Liu Y, Yu M, Mishra MK, Xu X, Ding X, Liu P, Liang M. Transfer RNA Fragments in the Kidney in Hypertension. Hypertension 2021;77:1627-37. [PMID: 33775129 DOI: 10.1161/HYPERTENSIONAHA.121.16994] [Reference Citation Analysis]
14 Elmarakby AA, Sullivan JC. Sex differences in hypertension: lessons from spontaneously hypertensive rats (SHR). Clin Sci (Lond) 2021;135:1791-804. [PMID: 34338771 DOI: 10.1042/CS20201017] [Reference Citation Analysis]
15 Kalk P, Godes M, Relle K, Rothkegel C, Hucke A, Stasch JP, Hocher B. NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy. Br J Pharmacol 2006;148:853-9. [PMID: 16770325 DOI: 10.1038/sj.bjp.0706792] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
16 Wang Y, Wang DH. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension. Am J Physiol Renal Physiol 2009;297:F1550-9. [PMID: 19794112 DOI: 10.1152/ajprenal.00012.2009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
17 Kondapi K, Kumar NL, Moorthy S, Silambanan S. A Study of Association of Urinary Nephrin with Albuminuria in Patients with Diabetic Nephropathy. Indian J Nephrol 2021;31:142-8. [PMID: 34267436 DOI: 10.4103/ijn.IJN_305_19] [Reference Citation Analysis]
18 Bloomgarden ZT. Blood pressure and diabetic nephropathy. Diabetes Care 2010;33:e30-5. [PMID: 20190283 DOI: 10.2337/dc10-zb03] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Iliescu R, Irwin ED, Georgakopoulos D, Lohmeier TE. Renal responses to chronic suppression of central sympathetic outflow. Hypertension 2012;60:749-56. [PMID: 22753216 DOI: 10.1161/HYPERTENSIONAHA.112.193607] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
20 Safar ME, Nilsson PM, Blacher J, Mimran A. Pulse pressure, arterial stiffness, and end-organ damage. Curr Hypertens Rep 2012;14:339-44. [PMID: 22555981 DOI: 10.1007/s11906-012-0272-9] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
21 Guan Z, Fellner RC, Van Beusecum J, Inscho EW. P2 receptors in renal autoregulation. Curr Vasc Pharmacol 2014;12:818-28. [PMID: 24066935 DOI: 10.2174/15701611113116660152] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
22 Zhou G, Li J, Zeng T, Yang P, Li A. The regulation effect of WNT-RAS signaling in hypothalamic paraventricular nucleus on renal fibrosis. J Nephrol 2020;33:289-97. [PMID: 31392659 DOI: 10.1007/s40620-019-00637-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Löhn M, Plettenburg O, Kannt A, Kohlmann M, Hofmeister A, Kadereit D, Monecke P, Schiffer A, Schulte A, Ruetten H. End-organ protection in hypertension by the novel and selective Rho-kinase inhibitor, SAR407899. World J Cardiol. 2015;7:31-42. [PMID: 25632317 DOI: 10.4330/wjc.v7.i1.31] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Bidani AK, Picken M, Hacioglu R, Williamson G, Griffin KA. Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance. Am J Physiol Renal Physiol 2007;292:F647-54. [PMID: 16968892 DOI: 10.1152/ajprenal.00017.2006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
25 van Loon LM, Rongen GA, van der Hoeven JG, Veltink PH, Lemson J. β-Blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure. Physiol Rep 2019;7:e14301. [PMID: 31814327 DOI: 10.14814/phy2.14301] [Reference Citation Analysis]
26 Zhang W, Zhang Y, Wang W, Dai Y, Ning C, Luo R, Sun K, Glover L, Grenz A, Sun H, Tao L, Zhang W, Colgan SP, Blackburn MR, Eltzschig HK, Kellems RE, Xia Y. Elevated ecto-5'-nucleotidase-mediated increased renal adenosine signaling via A2B adenosine receptor contributes to chronic hypertension. Circ Res 2013;112:1466-78. [PMID: 23584256 DOI: 10.1161/CIRCRESAHA.111.300166] [Cited by in Crossref: 59] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
27 Stanko P, Baka T, Repova K, Aziriova S, Krajcirovicova K, Barta A, Janega P, Adamcova M, Paulis L, Simko F. Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension. Front Med (Lausanne) 2020;7:325. [PMID: 32754607 DOI: 10.3389/fmed.2020.00325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Lins BB, Casare FAM, Fontenele FF, Gonçalves GL, Oliveira-Souza M. Long-Term Angiotensin II Infusion Induces Oxidative and Endoplasmic Reticulum Stress and Modulates Na+ Transporters Through the Nephron. Front Physiol 2021;12:642752. [PMID: 33868007 DOI: 10.3389/fphys.2021.642752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Wenzel RR. Renal protection in hypertensive patients: selection of antihypertensive therapy. Drugs 2005;65 Suppl 2:29-39. [PMID: 16398060 DOI: 10.2165/00003495-200565002-00005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
30 Shibata M, Sato KK, Uehara S, Koh H, Kinuhata S, Oue K, Kambe H, Morimoto M, Hayashi T. Blood pressure components and the risk for proteinuria in Japanese men: The Kansai Healthcare Study. J Epidemiol 2017;27:505-10. [PMID: 28709559 DOI: 10.1016/j.je.2016.10.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Griffin KA, Bidani AK. Potential risks of calcium channel blockers in chronic kidney disease. Curr Cardiol Rep 2008;10:448-55. [PMID: 18950553 DOI: 10.1007/s11886-008-0071-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
32 Chen J, Sgouralis I, Moore LC, Layton HE, Layton AT. A mathematical model of the myogenic response to systolic pressure in the afferent arteriole. Am J Physiol Renal Physiol 2011;300:F669-81. [PMID: 21190949 DOI: 10.1152/ajprenal.00382.2010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
33 Li W, Jiang YH, Wang Y, Zhao M, Hou GJ, Hu HZ, Zhou L. Protective Effects of Combination of Radix Astragali and Radix Salviae Miltiorrhizae on Kidney of Spontaneously Hypertensive Rats and Renal Intrinsic Cells. Chin J Integr Med 2020;26:46-53. [PMID: 31388973 DOI: 10.1007/s11655-019-3071-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
34 Dai Y, Zhang W, Wen J, Zhang Y, Kellems RE, Xia Y. A2B adenosine receptor-mediated induction of IL-6 promotes CKD. J Am Soc Nephrol 2011;22:890-901. [PMID: 21511827 DOI: 10.1681/ASN.2010080890] [Cited by in Crossref: 70] [Cited by in F6Publishing: 42] [Article Influence: 7.0] [Reference Citation Analysis]
35 Kim J, Lee J, Kim KN, Oh KH, Ahn C, Lee J, Kang D, Park SK. Association between Dietary Mineral Intake and Chronic Kidney Disease: The Health Examinees (HEXA) Study. Int J Environ Res Public Health 2018;15:E1070. [PMID: 29795052 DOI: 10.3390/ijerph15061070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
36 Nademi S, Lu C, Dickhout JG. Enhanced Myogenic Constriction in the SHR Preglomerular Vessels Is Mediated by Thromboxane A2 Synthesis. Front Physiol 2020;11:853. [PMID: 32792980 DOI: 10.3389/fphys.2020.00853] [Reference Citation Analysis]
37 Ashek A, Menzies RI, Mullins LJ, Bellamy CO, Harmar AJ, Kenyon CJ, Flatman PW, Mullins JJ, Bailey MA. Activation of thiazide-sensitive co-transport by angiotensin II in the cyp1a1-Ren2 hypertensive rat. PLoS One 2012;7:e36311. [PMID: 22558431 DOI: 10.1371/journal.pone.0036311] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
38 Huh JH, Ahn SV, Koh SB, Choi E, Kim JY, Sung KC, Kim EJ, Park JB. A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study. PLoS One 2015;10:e0143560. [PMID: 26618774 DOI: 10.1371/journal.pone.0143560] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
39 Bidani AK, Griffin KA, Williamson G, Wang X, Loutzenhiser R. Protective importance of the myogenic response in the renal circulation. Hypertension. 2009;54:393-398. [PMID: 19546375 DOI: 10.1161/hypertensionaha.109.133777] [Cited by in Crossref: 112] [Cited by in F6Publishing: 54] [Article Influence: 9.3] [Reference Citation Analysis]
40 Leong WB, Jadhakhan F, Taheri S, Thomas GN, Adab P. The Association between Obstructive Sleep Apnea on Diabetic Kidney Disease: A Systematic Review and Meta-Analysis. Sleep 2016;39:301-8. [PMID: 26414891 DOI: 10.5665/sleep.5432] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
41 Inscho EW. ATP, P2 receptors and the renal microcirculation. Purinergic Signal. 2009;5:447-460. [PMID: 19294530 DOI: 10.1007/s11302-009-9147-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
42 Guan Z, Pollock JS, Cook AK, Hobbs JL, Inscho EW. Effect of epithelial sodium channel blockade on the myogenic response of rat juxtamedullary afferent arterioles. Hypertension 2009;54:1062-9. [PMID: 19720952 DOI: 10.1161/HYPERTENSIONAHA.109.137992] [Cited by in Crossref: 46] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
43 Bidani AK, Griffin KA. Basic science: hypertensive target organ damage. J Am Soc Hypertens 2015;9:235-7; quiz 238. [PMID: 25670252 DOI: 10.1016/j.jash.2015.01.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
44 Amat N, Amat R, Abdureyim S, Hoxur P, Osman Z, Mamut D, Kijjoa A. Aqueous extract of dioscorea opposita thunb. normalizes the hypertension in 2K1C hypertensive rats. BMC Complement Altern Med 2014;14:36. [PMID: 24447776 DOI: 10.1186/1472-6882-14-36] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
45 Tanada Y, Okuda J, Kato T, Minamino-Muta E, Murata I, Soga T, Shioi T, Kimura T. The metabolic profile of a rat model of chronic kidney disease. PeerJ 2017;5:e3352. [PMID: 28560105 DOI: 10.7717/peerj.3352] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
46 Crowley SD, Zhang J, Herrera M, Griffiths R, Ruiz P, Coffman TM. Role of AT₁ receptor-mediated salt retention in angiotensin II-dependent hypertension. Am J Physiol Renal Physiol 2011;301:F1124-30. [PMID: 21849491 DOI: 10.1152/ajprenal.00305.2011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
47 Qureshi AI, Huang W, Lobanova I, Hanley DF, Hsu CY, Malhotra K, Steiner T, Suarez JI, Toyoda K, Yamamoto H; Antihypertensive Treatment of Cerebral Hemorrhage 2 Trial Investigators. Systolic Blood Pressure Reduction and Acute Kidney Injury in Intracerebral Hemorrhage. Stroke 2020;51:3030-8. [PMID: 32838673 DOI: 10.1161/STROKEAHA.120.030272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
48 Sasaki T, Tsuboi N, Haruhara K, Okabayashi Y, Kanzaki G, Koike K, Kobayashi A, Yamamoto I, Ogura M, Yokoo T. Bowman Capsule Volume and Related Factors in Adults With Normal Renal Function. Kidney Int Rep 2018;3:314-20. [PMID: 29725634 DOI: 10.1016/j.ekir.2017.10.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
49 Srivastava A, Palsson R, Kaze AD, Chen ME, Palacios P, Sabbisetti V, Betensky RA, Steinman TI, Thadhani RI, McMahon GM, Stillman IE, Rennke HG, Waikar SS. The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study. J Am Soc Nephrol 2018;29:2213-24. [PMID: 29866798 DOI: 10.1681/ASN.2017121260] [Cited by in Crossref: 53] [Cited by in F6Publishing: 26] [Article Influence: 17.7] [Reference Citation Analysis]
50 Castro P, Azevedo E, Rocha I, Sorond F, Serrador JM. Chronic kidney disease and poor outcomes in ischemic stroke: is impaired cerebral autoregulation the missing link? BMC Neurol 2018;18:21. [PMID: 29499637 DOI: 10.1186/s12883-018-1025-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
51 Tsuchida-Nishiwaki M, Uchida HA, Takeuchi H, Nishiwaki N, Maeshima Y, Saito C, Sugiyama H, Wada J, Narita I, Watanabe T, Matsuo S, Makino H, Hishida A, Yamagata K. Association of blood pressure and renal outcome in patients with chronic kidney disease; a post hoc analysis of FROM-J study. Sci Rep 2021;11:14990. [PMID: 34294784 DOI: 10.1038/s41598-021-94467-z] [Reference Citation Analysis]
52 Bidani AK, Griffin KA, Epstein M. Hypertension and chronic kidney disease progression: why the suboptimal outcomes? Am J Med 2012;125:1057-62. [PMID: 22906957 DOI: 10.1016/j.amjmed.2012.04.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
53 Banek CT, Gauthier MM, Van Helden DA, Fink GD, Osborn JW. Renal Inflammation in DOCA-Salt Hypertension. Hypertension 2019;73:1079-86. [PMID: 30879356 DOI: 10.1161/HYPERTENSIONAHA.119.12762] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
54 Safar ME. Arterial stiffness as a risk factor for clinical hypertension. Nat Rev Cardiol 2018;15:97-105. [PMID: 29022570 DOI: 10.1038/nrcardio.2017.155] [Cited by in Crossref: 97] [Cited by in F6Publishing: 59] [Article Influence: 24.3] [Reference Citation Analysis]
55 Dautzenberg M, Keilhoff G, Just A. Modulation of the myogenic response in renal blood flow autoregulation by NO depends on endothelial nitric oxide synthase (eNOS), but not neuronal or inducible NOS. J Physiol 2011;589:4731-44. [PMID: 21825026 DOI: 10.1113/jphysiol.2011.215897] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
56 Sun D, Eirin A, Zhu XY, Zhang X, Crane JA, Woollard JR, Lerman A, Lerman LO. Experimental coronary artery stenosis accelerates kidney damage in renovascular hypertensive swine. Kidney Int 2015;87:719-27. [PMID: 25337776 DOI: 10.1038/ki.2014.343] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
57 Ohno Y, Kanno Y, Takenaka T. Central blood pressure and chronic kidney disease. World J Nephrol 2016;5:90-100. [PMID: 26788468 DOI: 10.5527/wjn.v5.i1.90] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
58 Zheng Z, Waikar SS, Schmidt IM, Landis JR, Hsu CY, Shafi T, Feldman HI, Anderson AH, Wilson FP, Chen J, Rincon-Choles H, Ricardo AC, Saab G, Isakova T, Kallem R, Fink JC, Rao PS, Xie D, Yang W; CRIC Study Investigators. Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol 2021;32:639-53. [PMID: 33462081 DOI: 10.1681/ASN.2020030239] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
59 Guo F, Zhang W, Su J, Xu H, Yang H. Prediction of Drug Positioning for Quan-Du-Zhong Capsules Against Hypertensive Nephropathy Based on the Robustness of Disease Network. Front Pharmacol 2019;10:49. [PMID: 30809144 DOI: 10.3389/fphar.2019.00049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
60 Zhao W, Zhao T, Chen Y, Bhattacharya SK, Lu L, Sun Y. Differential Expression of Hypertensive Phenotypes in BXD Mouse Strains in Response to Angiotensin II. Am J Hypertens 2017;31:108-14. [PMID: 29036574 DOI: 10.1093/ajh/hpx144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Ma Z, Jin X, He L, Wang Y. CXCL16 regulates renal injury and fibrosis in experimental renal artery stenosis. Am J Physiol Heart Circ Physiol 2016;311:H815-21. [PMID: 27496882 DOI: 10.1152/ajpheart.00948.2015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
62 Guan Z, Fuller BS, Yamamoto T, Cook AK, Pollock JS, Inscho EW. Pentosan polysulfate treatment preserves renal autoregulation in ANG II-infused hypertensive rats via normalization of P2X1 receptor activation. Am J Physiol Renal Physiol 2010;298:F1276-84. [PMID: 20200092 DOI: 10.1152/ajprenal.00743.2009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
63 Charlton JR, Beeman SC, Bennett KM. MRI-detectable nanoparticles: the potential role in the diagnosis of and therapy for chronic kidney disease. Adv Chronic Kidney Dis. 2013;20:479-487. [PMID: 24206600 DOI: 10.1053/j.ackd.2013.06.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
64 Hildebrandt DA, Irwin ED, Lohmeier TE. Prolonged Baroreflex Activation Abolishes Salt-Induced Hypertension After Reductions in Kidney Mass. Hypertension 2016;68:1400-6. [PMID: 27777356 DOI: 10.1161/HYPERTENSIONAHA.116.08293] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
65 Li L, Feng D, Luo Z, Welch WJ, Wilcox CS, Lai EY. Remodeling of Afferent Arterioles From Mice With Oxidative Stress Does Not Account for Increased Contractility but Does Limit Excessive Wall Stress. Hypertension 2015;66:550-6. [PMID: 26101341 DOI: 10.1161/HYPERTENSIONAHA.115.05631] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
66 Deng Y, Zhang Q, Luo H, Chen X, Han Q, Wang F, Huang P, Lai W, Guan X, Pan X, Ji Y, Guo W, Che L, Tang Y, Gu L, Yu J, Namaka M, Deng Y, Li X. Sustained elevation of NF-κB activity sensitizes offspring of maternal inflammation to hypertension via impairing PGC-1α recovery. Sci Rep 2016;6:32642. [PMID: 27616627 DOI: 10.1038/srep32642] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
67 Nagase M. Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome. Clin Exp Nephrol 2010;14:303-14. [PMID: 20533072 DOI: 10.1007/s10157-010-0298-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
68 Polichnowski AJ, Licea-Vargas H, Picken M, Long J, Bisla R, Williamson GA, Bidani AK, Griffin KA. Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy. Am J Physiol Renal Physiol 2015;309:F791-9. [PMID: 26109088 DOI: 10.1152/ajprenal.00211.2015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
69 Zhang C, He X, Murphy SR, Zhang H, Wang S, Ge Y, Gao W, Williams JM, Geurts AM, Roman RJ, Fan F. Knockout of Dual-Specificity Protein Phosphatase 5 Protects Against Hypertension-Induced Renal Injury. J Pharmacol Exp Ther 2019;370:206-17. [PMID: 31118214 DOI: 10.1124/jpet.119.258954] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
70 Polichnowski AJ, Lu L, Cowley AW Jr. Renal injury in angiotensin II+L-NAME-induced hypertensive rats is independent of elevated blood pressure. Am J Physiol Renal Physiol 2011;300:F1008-16. [PMID: 21270093 DOI: 10.1152/ajprenal.00354.2010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
71 Safar ME. Mechanism(s) of Systolic Blood Pressure Reduction and Drug Therapy in Hypertension. Hypertension 2007;50:167-71. [DOI: 10.1161/hypertensionaha.107.088799] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
72 Fan L, Gao W, Nguyen BV, Jefferson JR, Liu Y, Fan F, Roman RJ. Impaired renal hemodynamics and glomerular hyperfiltration contribute to hypertension-induced renal injury. Am J Physiol Renal Physiol 2020;319:F624-35. [PMID: 32830539 DOI: 10.1152/ajprenal.00239.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
73 Bahous SA, Stephan A, Blacher J, Safar ME. Aortic Stiffness, Living Donors, and Renal Transplantation. Hypertension 2006;47:216-21. [DOI: 10.1161/01.hyp.0000201234.35551.2e] [Cited by in Crossref: 42] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
74 Weber GJ, Pushpakumar S, Tyagi SC, Sen U. Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension. Pharmacol Res 2016;113:300-12. [PMID: 27602985 DOI: 10.1016/j.phrs.2016.09.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
75 Shimada S, Abais-Battad JM, Alsheikh AJ, Yang C, Stumpf M, Kurth T, Mattson DL, Cowley AW Jr. Renal Perfusion Pressure Determines Infiltration of Leukocytes in the Kidney of Rats With Angiotensin II-Induced Hypertension. Hypertension 2020;76:849-58. [PMID: 32755400 DOI: 10.1161/HYPERTENSIONAHA.120.15295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
76 Bidani AK, Griffin KA. Chronic kidney disease: blood-pressure targets in chronic kidney disease. Nat Rev Nephrol 2011;7:128-30. [PMID: 21173790 DOI: 10.1038/nrneph.2010.168] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
77 Wang W, Chonchol M, Seals DR, Nowak KL. Dietary sodium restriction decreases urinary NGAL in older adults with moderately elevated systolic blood pressure free from chronic kidney disease. J Investig Med 2020;68:1271-5. [PMID: 32699180 DOI: 10.1136/jim-2020-001343] [Reference Citation Analysis]
78 Fotheringham J, Odudu A, Mckane W, Ellam T. Modification of the Relationship Between Blood Pressure and Renal Albumin Permeability by Impaired Excretory Function and Diabetes. Hypertension 2015;65:510-6. [DOI: 10.1161/hypertensionaha.114.04656] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
79 Griffin KA. Hypertensive Kidney Injury and the Progression of Chronic Kidney Disease. Hypertension 2017;70:687-94. [PMID: 28760941 DOI: 10.1161/HYPERTENSIONAHA.117.08314] [Cited by in Crossref: 38] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
80 van Varik BJ, Rennenberg RJ, Reutelingsperger CP, Kroon AA, de Leeuw PW, Schurgers LJ. Mechanisms of arterial remodeling: lessons from genetic diseases. Front Genet 2012;3:290. [PMID: 23248645 DOI: 10.3389/fgene.2012.00290] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
81 Xia Y, Entman ML, Wang Y. Critical role of CXCL16 in hypertensive kidney injury and fibrosis. Hypertension 2013;62:1129-37. [PMID: 24060897 DOI: 10.1161/HYPERTENSIONAHA.113.01837] [Cited by in Crossref: 69] [Cited by in F6Publishing: 40] [Article Influence: 8.6] [Reference Citation Analysis]
82 Aune D, Huang W, Nie J, Wang Y. Hypertension and the Risk of All-Cause and Cause-Specific Mortality: An Outcome-Wide Association Study of 67 Causes of Death in the National Health Interview Survey. Biomed Res Int 2021;2021:9376134. [PMID: 34337061 DOI: 10.1155/2021/9376134] [Reference Citation Analysis]
83 Bidani AK, Polichnowski AJ, Loutzenhiser R, Griffin KA. Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertens 2013;22:1-9. [PMID: 23132368 DOI: 10.1097/MNH.0b013e32835b36c1] [Cited by in Crossref: 93] [Cited by in F6Publishing: 50] [Article Influence: 11.6] [Reference Citation Analysis]
84 Bidani AK, Polichnowski AJ, Licea-Vargas H, Long J, Kliethermes S, Williamson GA, Griffin KA. BP Fluctuations and the Real-Time Dynamics of Renal Blood Flow Responses in Conscious Rats. J Am Soc Nephrol 2020;31:324-36. [PMID: 31792155 DOI: 10.1681/ASN.2019070718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
85 Xia Y, Jin X, Yan J, Entman ML, Wang Y. CXCR6 plays a critical role in angiotensin II-induced renal injury and fibrosis. Arterioscler Thromb Vasc Biol 2014;34:1422-8. [PMID: 24855055 DOI: 10.1161/ATVBAHA.113.303172] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.9] [Reference Citation Analysis]
86 Ohnishi K, Murase M, Nakano D, Pelisch N, Hitomi H, Kobori H, Morimoto S, Mori H, Masaki T, Ohmori K, Kohno M, Ichihara A, Nishiyama A. Angiotensin-converting enzyme inhibitor does not suppress renal angiotensin II levels in angiotensin I-infused rats. J Pharmacol Sci 2013;122:103-8. [PMID: 23698111 DOI: 10.1254/jphs.13045fp] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
87 Miyaoka Y, Okada T, Tomiyama H, Morikawa A, Rinno S, Kato M, Tsujimoto R, Suzuki R, China R, Nagai M, Nagaoka Y, Nagao T, Kanno Y. Structural changes in renal arterioles are closely associated with central hemodynamic parameters in patients with renal disease. Hypertens Res 2021;44:1113-21. [PMID: 33859396 DOI: 10.1038/s41440-021-00656-8] [Reference Citation Analysis]
88 Singh P, Faisal AR, Sheikh AU, Alam MM, Faizan M, Neupane P, Uzair M, Acharya A, Saeed A, Akhtar FN. An Evaluation of Socio-Demographic and Risk Factor Profile in End-Stage Renal Disease Patients: A Cross-Sectional Assessment. Cureus 2021;13:e16353. [PMID: 34395131 DOI: 10.7759/cureus.16353] [Reference Citation Analysis]
89 Higashiura Y, Furuhashi M, Tanaka M, Takahashi S, Mori K, Miyamori D, Koyama M, Ohnishi H, Moniwa N, Numata K, Hisasue T, Hanawa N, Miura T. Elevated Fatty Liver Index Is Independently Associated With New Onset of Hypertension During a 10-Year Period in Both Male and Female Subjects. J Am Heart Assoc 2021;10:e021430. [PMID: 34259033 DOI: 10.1161/JAHA.121.021430] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Eirin A, Lerman A, Lerman LO. Mitochondria: a pathogenic paradigm in hypertensive renal disease. Hypertension 2015;65:264-70. [PMID: 25403611 DOI: 10.1161/HYPERTENSIONAHA.114.04598] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 5.9] [Reference Citation Analysis]
91 Chang AR, Kramer H, Wei G, Boucher R, Grams ME, Berlowitz D, Bhatt U, Cohen DL, Drawz P, Punzi H, Freedman BI, Haley W, Hawfield A, Horwitz E, McLouth C, Morisky D, Papademetriou V, Rocco MV, Wall B, Weiner DE, Zias A, Beddhu S; SPRINT Research Group. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria: Post Hoc Analyses from SPRINT. Clin J Am Soc Nephrol 2020;15:1121-8. [PMID: 32669306 DOI: 10.2215/CJN.12371019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
92 Pimenta E, Gaddam KK, Pratt-ubunama MN, Nishizaka MK, Aban I, Oparil S, Calhoun DA. Relation of Dietary Salt and Aldosterone to Urinary Protein Excretion in Subjects With Resistant Hypertension. Hypertension 2008;51:339-44. [DOI: 10.1161/hypertensionaha.107.100701] [Cited by in Crossref: 51] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
93 Zhang MZ, Wang S, Yang S, Yang H, Fan X, Takahashi T, Harris RC. Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice. Am J Physiol Renal Physiol 2012;302:F433-8. [PMID: 22114203 DOI: 10.1152/ajprenal.00292.2011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
94 Merzkani MA, Mullan A, Denic A, D'Costa M, Iverson R, Kremers W, Alexander MP, Textor SC, Taler SJ, Stegall MD, Augustine J, Issa N, Rule AD. Renal function outcomes and kidney biopsy features of living kidney donors with hypertension. Clin Transplant 2021;35:e14293. [PMID: 33745214 DOI: 10.1111/ctr.14293] [Reference Citation Analysis]
95 Polichnowski AJ, Lan R, Geng H, Griffin KA, Venkatachalam MA, Bidani AK. Severe renal mass reduction impairs recovery and promotes fibrosis after AKI. J Am Soc Nephrol 2014;25:1496-507. [PMID: 24511135 DOI: 10.1681/ASN.2013040359] [Cited by in Crossref: 47] [Cited by in F6Publishing: 28] [Article Influence: 6.7] [Reference Citation Analysis]
96 Polichnowski AJ, Cowley AW Jr. Pressure-induced renal injury in angiotensin II versus norepinephrine-induced hypertensive rats. Hypertension 2009;54:1269-77. [PMID: 19858406 DOI: 10.1161/HYPERTENSIONAHA.109.139287] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
97 Gosmanova EO, Kovesdy CP. Blood Pressure Targets in CKD: Lessons Learned from SPRINT and Previous Observational Studies. Curr Cardiol Rep 2016;18:88. [PMID: 27448402 DOI: 10.1007/s11886-016-0769-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
98 Polichnowski AJ, Griffin KA, Picken MM, Licea-Vargas H, Long J, Williamson GA, Bidani AK. Hemodynamic basis for the limited renal injury in rats with angiotensin II-induced hypertension. Am J Physiol Renal Physiol 2015;308:F252-60. [PMID: 25477472 DOI: 10.1152/ajprenal.00596.2014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
99 Cao X, Bian JS. The Role of Hydrogen Sulfide in Renal System. Front Pharmacol 2016;7:385. [PMID: 27803669 DOI: 10.3389/fphar.2016.00385] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 11.4] [Reference Citation Analysis]
100 Pugh D, Gallacher PJ, Dhaun N. Management of Hypertension in Chronic Kidney Disease. Drugs 2019;79:365-79. [PMID: 30758803 DOI: 10.1007/s40265-019-1064-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 19] [Article Influence: 19.5] [Reference Citation Analysis]